1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > China Contract Research Organization (CRO) Industry Report, 2015-2018

In recent years, China's contract research organization (CRO) industry has developed rapidly, with the market size rising from RMB8.5 billion in 2007 to RMB42.6 billion in 2014, registering a CAGR of 25.9%. With so many favorable policies, especially when a number of well-known proprietary drugs are about to expire, China’s CRO market size is expected to continue to grow by around 20% in the years ahead, to an estimated RMB 83.2 billion by 2018.

At present, some European and American CRO enterprises represented by Quintiles and Covance have penetrated the Chinese market by establishing branches or through acquisition and cooperation. These foreign giants, which occupy the majority of China’s CRO market share, are driving the industry to develop toward standardization.

There are more than 500 Chinese CRO enterprises, such as WuXi AppTec, Tigermed Consulting, Boji Medical Biotechnological, and HD Biosciences, which have a relatively large scale and develop very well. In 2014, WuXi AppTec represented a 9.69% market share while Tigermed Consulting and Boji Medical Biotechnological accounted for 1.47% and 0.34%, respectively.

As a leader in China’s CRO industry, WuXi AppTec posted revenue of RMB4.1266 billion (equivalent to USD674.3 million) in 2014, up 16.6% from a year earlier. In recent years, the company has seen rapid expansion by acquiring AppTec, ABGENT, Shanghai Medkey Med-Tech Development Co., and NextCODE Health.

Tigermed Consulting is a CRO company that specializes in the services related to clinical trials and clinical research. In 2014, the company recorded RMB624.6 million in revenue, up as high as 85.6%. In August 2012, the company completed its IPO, and then continuously strengthened its competitiveness through M&A and investment in subsidiaries. During 2013-2014, Tigermed Consulting founded Fantastic Bioimaging, Shanghai Tigermed Consulting Co., Hangzhou Talent MedCinsultant, and Tigermed-IntelliPV Ltd., and purchased BDM and Frontage Labs. In 2015, the company announced a proposed acquisition of Beiyi Renzhi (Beijing) Medical Technology Development Co. and DreamCIS Inc, a South Korean company.

Boji Medical Biotechnological, a comprehensive CRO company, was publicly traded on GEM of Shenzhen Stock Exchange in April 2015. As of the end of 2014, it had provided an accumulated more than 400 clinical research services and over 200 preclinical research services. In recent years, it has begun to focus on international expansion, successively undertaking the service projects of some overseas companies including Sweden’s Astrom Research International and South Korea’s Hyundai Pharmaceutical.

China Contract Research Organization (CRO) Industry Report, 2015-2018 is mainly all about the following:
Status quo, related policies, market size, competitive landscape, development trends, etc. of China’s CRO industry;
Development environment of China’s CRO industry, including international environment, industry environment, and regional market;
Operation, R&D and investment, development in China, etc. of 5 global and 13 Chinese CRO companies;
Development prediction of China’s CRO industry as well as operation of major enterprises.

Table Of Contents

China Contract Research Organization (CRO) Industry Report, 2015-2018
1. Overview of Pharmaceutical Outsourcing
1.1 Definition
1.2 Classification
1.3 CRO

2. Overview of China CRO Market
2.1 Status Quo
2.2 Related Policies
2.3 Market Size
2.4 Competitive Landscape
2.5 Development Trends
2.5.1 Industrial Chain Improvement
2.5.2 Internationalization of Qualification Certification Standard
2.5.3 Development Driven by Technical Innovation

3. Development Environment of China CRO Industry
3.1 International Environment
3.1.1 Development History
3.1.2 Development Status
3.1.3 Major Countries and Regions
3.2 Industry Environment
3.3 Regional Market
3.3.1 Beijing
3.3.2 Shanghai
3.3.3 Chengdu

4. Key Chinese CRO Players
4.1 Wuxi AppTec
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Gross Margin
4.1.5 Investment and Development
4.1.6 Forecast and Outlook
4.2 Hangzhou Tigermed Consulting Co., Ltd.
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Gross Margin
4.2.5 RandD and Investment
4.2.6 Forecast and Outlook
4.3 Guangzhou Boji Medical Biotechnological Co., Ltd.
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 RandD and Investment
4.3.6 Forecast and Outlook
4.4 ShangPharma Corp
4.4.1 Profile
4.4.2 Operation
4.4.3 Gross Margin
4.5 China Medical Technologies Inc.
4.5.1 Profile
4.5.2 Operation
4.5.3 Gross Margin
4.5.4 Development
4.6 Asymchem
4.6.1 Profile
4.6.2 Operation
4.6.3 Revenue Structure
4.6.4 Gross Margin
4.6.5 RandD and Investment
4.6.6 Forecast and Outlook
4.7 HD Biosciences
4.7.1 Profile
4.7.2 Operation
4.7.3 Development
4.8 Porton
4.8.1 Profile
4.8.2 Operation
4.8.3 Revenue Structure
4.8.4 Gross Margin
4.8.5 RandD and Investment
4.8.6 Forecast and Outlook
4.9 Others
4.9.1 Shanghai Mediclon Inc.
4.9.2 Sundia MediTech Company Ltd.
4.9.3 Guangzhou Yushi Medicinal Technology Co., Ltd.
4.9.4 JOINN Laboratories (Beijing)

5. Key Foreign CRO Companies
5.1 Covance
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Development in China
5.2 Parexel
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Development in China
5.3 Quintiles
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 Development in China
5.4 Charles River
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.4.5 Development in China
5.5 PPD
5.5.1 Profile
5.5.2 Operation
5.5.3 Revenue Structure
5.5.4 Development in China

6. Development and Outlook
6.1 Industry Development Prediction
6.2 Operation of Major CRO Companies
6.2.1 Revenue
6.2.2 Net Income
6.2.3 Gross Margin


Companies Mentioned
Wuxi AppTec
Hangzhou Tigermed Consulting Co., Ltd.
Guangzhou Boji Medical Biotechnological Co., Ltd.
ShangPharma Corp
China Medical Technologies Inc.
Asymchem
HD Biosciences
Porton
Shanghai Mediclon Inc.
Sundia MediTech Company Ltd.
Guangzhou Yushi Medicinal Technology Co., Ltd.
JOINN Laboratories (Beijing)
Covance
Parexel
Quintiles
Charles River
PPD

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global bioinformatics market is projected to reach USD 16.18 billion by 2021 from USD 6.21 billion in 2016, growing at a CAGR of 21.1% during the forecast period. In this report, the bioinformatics ...

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.